OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Neurology is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
	109
Comparative features and outcomes of major neurological complications of COVID‐19	105
	95
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis	92
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	90
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	89
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	88
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	87
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	87
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	76
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	71
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	71
Prioritization process for European Academy of Neurology clinical practice guidelines	66
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms	63
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	58
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	57
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study	56
The microbiome–gut–brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications	56
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities	56
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	55
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	54
Mirror therapy for unilateral neglect after stroke: A systematic review	52
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	50
Risk factors, neuroimaging correlates and prognosis of the motoric cognitive risk syndrome: A population‐based comparison with mild cognitive impairment	50
Issue Information	49

Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	49
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	48
ePoster	45
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	45
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis	43
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	43
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	43
Neuropathy in GAA‐FGF14 Late‐Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics	43
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	42
Lessons from the past to understand the future	42
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	42
Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications	41
The effect of influenza vaccination on the rate of dementia amongst older adults	41
Long‐term MRI changes in a patient with Kelch‐like protein 11‐associated paraneoplastic neurological syndrome	40
Central nervous system crystal‐storing histiocytosis: A case report and literature review	40
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	40
Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study	40